Ng Domingos, Zhou Meixia, Zhan Dejin, Yip Shirley, Ko Peggy, Yim Mandy, Modrusan Zora, Joly John, Snedecor Brad, Laird Michael W, Shen Amy
Department of Cell Culture and Bioprocess Operations, Genentech, Inc., San Francisco, California, USA.
DNA Sequencing Lab, Genentech, Inc., San Francisco, California, USA.
Biotechnol Prog. 2021 Jul;37(4):e3140. doi: 10.1002/btpr.3140. Epub 2021 Apr 9.
Cell line development (CLD) by random integration (RI) can be labor intensive, inconsistent, and unpredictable due to uncontrolled gene integration after transfection. Unlike RI, targeted integration (TI) based CLD introduces the antibody-expressing cassette to a predetermined site by recombinase-mediated cassette exchange (RMCE). The key to success for the development of a TI host for therapeutic antibody production is to identify a transcriptionally active hotspot that enables highly efficient RMCE and antibody expression with good stability. In this study, a genome wide search for hotspots in the Chinese hamster ovary (CHO)-K1-M genome by either RI or PiggyBac (PB) transposase-based integration has been described. Two CHO-K1-M derived TI host cells were established with the Cre/Lox RMCE system and are described here. Both TI hosts contain a GFP-expressing landing pad flanked by two incompatible LoxP recombination sites (L3 and 2L). In addition, a third incompatible LoxP site (LoxFAS) is inserted in the GFP landing pad to enable an innovative two-plasmid based RMCE strategy, in which two separate vectors can be targeted to a single locus simultaneously. Cell lines generated by the TI system exhibit comparable or higher productivity, better stability and fewer sequence variant (SV) occurrences than the RI cell lines.
通过随机整合(RI)进行细胞系开发(CLD)可能会因转染后基因整合不受控制而耗费大量人力、结果不一致且不可预测。与RI不同,基于靶向整合(TI)的CLD通过重组酶介导的盒式交换(RMCE)将抗体表达盒引入预定位点。开发用于治疗性抗体生产的TI宿主的成功关键在于识别一个转录活性热点,该热点能够实现高效的RMCE和具有良好稳定性的抗体表达。在本研究中,描述了通过RI或基于猪尾巴(PB)转座酶的整合在中国仓鼠卵巢(CHO)-K1-M基因组中进行全基因组热点搜索的过程。利用Cre/Lox RMCE系统建立了两种源自CHO-K1-M的TI宿主细胞,并在此进行描述。两种TI宿主均包含一个由两个不相容的LoxP重组位点(L3和2L)侧翼的表达绿色荧光蛋白(GFP)的着陆平台。此外,第三个不相容的LoxP位点(LoxFAS)插入到GFP着陆平台中,以实现一种创新的基于双质粒的RMCE策略,其中两个单独的载体可以同时靶向单个位点。与RI细胞系相比,由TI系统产生的细胞系表现出相当或更高的生产力、更好的稳定性以及更少的序列变异(SV)发生情况。